Critical Limb Ischemia

Aastrom To Refocus Research On Dilated Cardiomyopathy, Cut StaffAastrom Biosciences Inc., a developer of patient-specific expanded multicellular therapies for the treatment of severe chronic diseases, announced a strategic change in its research and development programs to focus on the clinical development of its lead product, ixmyelocel-T, for the treatment of dilated cardiomyopathy.
Aastrom Board Names Dominick C. Colangelo President, CEOAastrom Biosciences Inc. announced that the company’s board of directors has named Dominick C. Colangelo as president and CEO.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen